Annual report [Section 13 and 15(d), not S-K Item 405]

Statements of Operations

v3.25.1
Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Licensing revenues $ 675
Operating expenses:    
Research and development 20,014 12,902
General and administrative 12,103 8,547
Total operating expenses 32,117 21,449
Loss from operations (32,117) (20,774)
Other income (expenses):    
Interest income 1,261 615
Interest expense (71) (82)
Change in fair value of warrants (5,802) (10,303)
Total other income (expenses) (4,612) (9,770)
Net loss (36,729) (30,544)
Deemed dividend to Series A-1 preferred stockholders (867)
Dividends on Series B-1 Preferred Stock (1,095)
Net loss attributable to common stockholders $ (37,824) $ (31,411)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (0.56) $ (1.28)
Net loss per share attributable to common stockholders, Diluted (in Dollars per share) $ (0.56) $ (1.28)
Weighted-average shares outstanding used in computing net loss per share, basic (in Shares) 66,985,129 24,539,309
Weighted-average shares outstanding used in computing net loss per share, Diluted (in Shares) 66,985,129 24,539,309